Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-22 · accession 0001193522-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-12-23 | 2025-12-22 | UTHR | SULLIVAN LOUIS W | Dir | M - OptEx | $204.93 | +5,950 | 3,230 | New | +$1.22M |
| DMI | 2025-12-23 | 2025-12-22 | UTHR | SULLIVAN LOUIS W | Dir | S - Sale+OE | $512.14 | -5,950 | 4,863 | -55% | -$3.05M |
| DMI | 2025-12-23 | 2025-12-22 | UTHR | SULLIVAN LOUIS W | Dir | M - OptEx | $0.00 | -5,950 | 1,840 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | M | A | 2,720 | $229.81 | 5,950 | I by Trust | — | — | (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |
| 2 | Common | Common Stock | 2025-12-22 | S | D | 4,863 | $512.34 | 0 | I by Trust | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $511.67 to $512.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |
| 3 | Common | Common Stock | 2025-12-22 | S | D | 1,087 | $511.22 | 4,863 | I by Trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $510.64 to $511.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |
| 4 | Common | Common Stock | 2025-12-22 | M | A | 3,230 | $183.98 | 3,230 | I by Trust | — | — | (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |
| 5 | Derivative | Stock Options | 2025-12-22 | M | D | 3,230 | $0.00 | 0 | I By Trust | $183.98 · 2022-07-08 to 2031-07-08 | 3,230 Common Stock | (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |
| 6 | Derivative | Stock Options | 2025-12-22 | M | D | 2,720 | $0.00 | 1,840 | I By Trust | $229.81 · 2024-07-13 to 2033-07-13 | 2,720 Common Stock | (F1) These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. |